This is the second part of a series of posts on biomarkers.  For the first one, click here… The pharma industry, investors and company founders are now realising the potential of biomarkers to transform drug discovery and development.  Worldwide, major bio industry conferences are Read more...

Attending a life science conference recently, I was suddenly struck by the dramatic change in perception that has occurred regarding the relevance of biomarkers to drug discovery and development. It was heartening to see, not least because I was part of the industrialisation of genomics research Read more...

Sales teams, especially ones working in my area of preclinical and clinical development services LOVE website enquiries. “Gotchas”, they call them. As a starting point along a long sales process to closure, the website sales lead is better than most.  A person has taken the time to Read more...

Yesterday’s publication of PriceWaterhouseCooper’s evaluation of the biotechnology industry provides some sobering reading.  Amongst the doom and gloom there’s promise and some pointers for where this industry’s service providers should look for securing and growing Read more...

How many times have you seen this scenario: the end of the month is approaching, the revenue forecast is looking decidedly shaky and your business development team are grappling for a lucky last-minute break so that everyone can relax for another few weeks? Then it happens: Panic.  Read more...